MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
4.91 M |
Marktkapitalisierung |
$ 2.26 M |
EBITDA (LTM) |
$ -2.4 M |
P/E (LTM) |
-1.384615 |
P/S (LTM) |
- |
EPS (LTM) |
-0.39 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
EyePoint Pharmaceuticals
EYPT
|
$ 3.15 | 0.62 % | $ 231 K | Nasdaq Global Market | USA |
 |
Fate Therapeutics
FATE
|
$ 2.43 | 4.74 % | $ 289 M | Nasdaq Global Market,SPB | USA |
 |
Fortress Biotech
FBIO
|
$ 2.09 | 2.96 % | $ 58.3 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.62 | 4.12 % | $ 303 M | Nasdaq Capital Market | USA |
 |
Fulcrum Therapeutics
FULC
|
$ 3.71 | 0.54 % | $ 235 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
Galectin Therapeutics
GALT
|
$ 3.73 | 3.72 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Geron Corporation
GERN
|
$ 1.21 | 0.83 % | $ 807 M | Nasdaq Global Select Market | USA |
 |
Gilead Sciences
GILD
|
$ 144.63 | 0.85 % | $ 180 B | Nasdaq Global Select Market,SPB | USA |
 |
Greenwich LifeSciences
GLSI
|
$ 16.91 | 0.77 % | $ 229 M | Nasdaq Capital Market | USA |
 |
Genmab A/S
GMAB
|
$ 38.48 | 10.73 % | $ 2.49 B | Nasdaq Global Select Market |  Danmark |
 |
Genprex
GNPX
|
$ 2.72 | 3.42 % | $ 2.54 M | Nasdaq Capital Market | USA |
 |
Gossamer Bio
GOSS
|
$ 10.65 | 0.37 % | $ 2.43 B | Nasdaq Global Select Market,SPB | USA |
 |
GeoVax Labs
GOVX
|
$ 0.32 | 1.31 % | $ 307 K | Nasdaq Global Select Market | USA |
 |
Grifols, S.A.
GRFS
|
$ 7.41 | 1.37 % | $ 5.04 B | Nasdaq Global Select Market |  Spain |
 |
GlaxoSmithKline plc
GSK
|
$ 46.55 | 0.93 % | $ 189 B | NYSE |  Britain |
 |
GT Biopharma
GTBP
|
$ 6.16 | 0.98 % | $ 34 M | Nasdaq Capital Market | USA |
 |
Halozyme Therapeutics
HALO
|
$ 108.31 | 2.73 % | $ 13 B | Nasdaq Global Select Market,SPB | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 14.31 | 0.77 % | $ 12.3 B | Nasdaq Global Select Market |  China |
 |
Harmony Biosciences Holdings
HRMY
|
$ 39.92 | 0.71 % | $ 2.3 B | Nasdaq Global Select Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.37 | 6.44 % | $ 61.7 M | Nasdaq Global Select Market,SPB | USA |
 |
iBio
IBIO
|
$ 1.12 | 0.89 % | $ 117 M | NYSE American | USA |
 |
ImmuCell Corporation
ICCC
|
$ 9.75 | 1.56 % | $ 88 M | Nasdaq Global Select Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 38.06 | 1.87 % | $ 3.37 B | Nasdaq Global Select Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.68 | 0.58 % | $ 113 M | Nasdaq Global Select Market |  Germany |
 |
Immutep Limited
IMMP
|
$ 4.27 | 0.46 % | $ 6.22 B | Nasdaq Global Market |  Australia |
 |
Immunome
IMNM
|
$ 21.17 | 1.29 % | $ 1.85 B | Nasdaq Global Select Market | USA |
 |
Immuron Limited
IMRN
|
$ 1.07 | 0.46 % | $ 247 M | Nasdaq Global Select Market | Australia |
 |
Immatics N.V.
IMTX
|
$ 7.73 | 1.84 % | $ 946 M | Nasdaq Global Select Market | Germany |
 |
Immunic
IMUX
|
$ 8.07 | 1.38 % | $ 1.26 B | Nasdaq Global Select Market | USA |
 |
Immunovant
IMVT
|
$ 33.25 | 0.18 % | $ 6.07 B | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.58 | 1.28 % | $ 142 M | Nasdaq Global Select Market |  France |
 |
Incyte Corporation
INCY
|
$ 114.13 | 0.06 % | $ 22.3 B | Nasdaq Global Select Market,SPB | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.33 | 0.01 % | $ 5.54 M | Nasdaq Capital Market |  Canada |
 |
INmune Bio
INMB
|
$ 1.94 | 0.52 % | $ 48 M | Nasdaq Capital Market | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.15 | 2.05 % | $ 53.9 M | Nasdaq Global Select Market | USA |
 |
Insmed Incorporated
INSM
|
$ 103.83 | 2.33 % | $ 20.7 B | Nasdaq Global Select Market | USA |
 |
Innoviva
INVA
|
$ 20.64 | 0.68 % | $ 1.39 B | Nasdaq Global Select Market | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 14.15 | 0.63 % | $ 5.06 M | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.65 | 0.27 % | $ 591 M | Nasdaq Global Select Market | USA |
 |
Inventiva S.A.
IVA
|
$ 3.48 | 2.89 % | $ 208 M | Nasdaq Global Market | France |
 |
Jaguar Health
JAGX
|
$ 4.73 | 29.23 % | $ 11 M | Nasdaq Capital Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 236.04 | 0.16 % | $ 14.4 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 252.93 | 0.03 % | $ 609 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.36 | 0.86 % | $ 2.93 M | Nasdaq Global Select Market | USA |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 76.31 | 0.69 % | $ 5.66 B | Nasdaq Global Select Market | USA |
 |
Kodiak Sciences
KOD
|
$ 93.81 | 0.32 % | $ 4.99 B | Nasdaq Global Market,SPB | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.67 | 1.51 % | $ 7.33 K | Nasdaq Global Select Market | USA |
 |
Keros Therapeutics
KROS
|
$ 11.52 | 1.41 % | $ 429 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 334.85 | 3.9 % | $ 9.69 B | Nasdaq Global Market,SPB | USA |